Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06410417
NA

Ejaculation Abstinence Time and Assisted Reproductive Technology Outcomes

Sponsor: The First Hospital of Jilin University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if reducing the ejaculation abstinence time can improve the outcome of assisted reproductive technology. The main questions it aims to answer are: Does reducing the duration of ejaculation abstinence improve the clinical pregnancy rate for in vitro fertilization and intracytoplasmic sperm injection? Does reducing the duration of ejaculation abstinence improve embryo quality in in vitro fertilization and intracytoplasmic sperm injection? Does reducing the duration of ejaculation abstinence affect pregnancy loss and live birth rates in in vitro fertilization and intracytoplasmic sperm injection? Researchers will compare less than 48 hours of abstinence time to more than 48 hours, to see if less than 48 hours of abstinence time improved in vitro fertilization outcomes Participants will: Control group abstinence for 3-7 days The experimental group ejaculated once on human chorionic gonadotropin trigger day Follow up their in vitro fertilization outcomes

Official title: The Effect of Reducing Ejaculation Abstinence Time on Assisted Reproductive Technology Outcomes: a Prospective Randomized Controlled Study

Key Details

Gender

All

Age Range

20 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

500

Start Date

2024-05-01

Completion Date

2025-08-01

Last Updated

2024-05-13

Healthy Volunteers

Yes

Interventions

BEHAVIORAL

Shorten abstinence time

In the experimental group, male ejaculates once on human chorionic gonadotropin trigger day, and can be ejaculated on the second day if ejaculates fail.

Locations (1)

the first hospital of Jilin University

Changchun, Jilin, China